CLSI POCT14

Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE

Clinical and Laboratory Standards Institute, 07/27/2020

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:27/07/2020

Pages:68

File Size:1 file , 6.8 MB

Note:This product is unavailable in Russia, Belarus

This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.

More CLSI standard pdf

CLSI H52A

Fetal Red Cell Detection; Approved Guideline, H52-A

$101.00 $202.74

CLSI H15-A3

Reference and Selected Procedures for the Quantitative Determination of Hemoglobin in Blood; Approved Standard, H15-A3

$121.00 $242.51

CLSI H02A4

Reference and Selected Procedure for the Erythrocyte Sedimentation Rate (ESR) Test; Approved Standard, H02-A4

$137.00 $275.77

CLSI NRSCL13A

The Reference System for the Clinical Laboratory: Criteria for Development and Credentialing of Methods and Materials for Harmonization of Results; Approved Guideline, NRSCL13-A

$108.00 $216.52